Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.


Journal

Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036

Informations de publication

Date de publication:
03 2021
Historique:
received: 09 05 2020
revised: 03 11 2020
accepted: 13 11 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 9 3 2021
Statut: epublish

Résumé

Febrile infection-related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy that presents suddenly in otherwise normal children and young adults causing significant neurological disability, chronic epilepsy, and high rates of mortality. To suggest a therapy protocol to improve outcome of FIRES, workshops were held in conjunction with American Epilepsy Society annual meeting between 2017 and 2019. An international group of pediatric epileptologists, pediatric neurointensivists, rheumatologists and basic scientists with interest and expertise in FIRES convened to propose an algorithm for a standardized approach to the diagnosis and treatment of FIRES. The broad differential for refractory status epilepticus (RSE) should include FIRES, to allow empiric therapies to be started early in the clinical course. FIRES should be considered in all previously healthy patients older than two years of age who present with explosive onset of seizures rapidly progressing to RSE, following a febrile illness in the preceding two weeks. Once FIRES is suspected, early administrations of ketogenic diet and anakinra (the IL-1 receptor antagonist that blocks biologic activity of IL-1β) are recommended.

Identifiants

pubmed: 33681649
doi: 10.1002/epi4.12447
pmc: PMC7918329
doi:

Substances chimiques

Interleukin 1 Receptor Antagonist Protein 0
Cannabidiol 19GBJ60SN5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

62-72

Informations de copyright

© 2020 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Déclaration de conflit d'intérêts

Sookyong Koh applied and received unrestricted educational grant from Sobi to hold FIRES Workshops. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Références

Neurobiol Dis. 2015 Oct;82:311-320
pubmed: 26168875
Neuropediatrics. 2017 Feb;48(1):5-18
pubmed: 27919115
J Neurol Sci. 2016 Sep 15;368:272-6
pubmed: 27538648
Nat Med. 2015 Mar;21(3):263-9
pubmed: 25686106
Epilepsia. 2011 Nov;52(11):1956-65
pubmed: 21883180
Epilepsia. 2011 May;52 Suppl 3:26-32
pubmed: 21542843
Epilepsia. 2016 Sep;57(9):e191-4
pubmed: 27381590
Epilepsia Open. 2019 Mar 27;4(2):344-350
pubmed: 31168503
Ann Neurol. 2016 Dec;80(6):939-945
pubmed: 27770579
Seizure. 2018 Mar;56:53-59
pubmed: 29453111
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):820-2
pubmed: 25398790
Ann Neurol. 2018 Dec;84(6):940-945
pubmed: 30408233
Epilepsia. 2002;43 Suppl 5:30-5
pubmed: 12121291
J Neurosci. 2010 Jun 2;30(22):7484-94
pubmed: 20519523
Ann Neurol. 2019 Apr;85(4):526-537
pubmed: 30779222
Pharmacol Res. 2016 Aug;110:96-100
pubmed: 27173399
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11534-9
pubmed: 11016948
Neurotherapeutics. 2011 Apr;8(2):304-15
pubmed: 21431948
Dev Med Child Neurol. 2020 Aug;62(8):897-905
pubmed: 32372459
Neurobiol Dis. 2009 Feb;33(2):171-81
pubmed: 19010416
Ann Neurol. 2005 Jan;57(1):152-5
pubmed: 15622539
Neurobiol Dis. 2008 Jan;29(1):142-60
pubmed: 17931873
Epilepsia. 2017 Aug;58(8):1340-1348
pubmed: 28555777
J Neuroinflammation. 2016 Nov 28;13(1):298
pubmed: 27894304
Neurobiol Dis. 2017 Mar;99:12-23
pubmed: 27939857
J Neuroinflammation. 2018 Feb 09;15(1):38
pubmed: 29426321
J Neurol. 2021 May;268(5):1689-1707
pubmed: 31655889
Epilepsia. 2012 Jan;53(1):101-10
pubmed: 22191582
Epilepsia. 2010 Oct;51(10):2033-7
pubmed: 20813015
Epilepsia. 2010 Jul;51 Suppl 3:34-8
pubmed: 20618397
Ann Clin Transl Neurol. 2020 Dec;7(12):2467-2474
pubmed: 33506622
Epilepsia. 2015 Jul;56(7):e95-8
pubmed: 26011473
Nat Rev Neurosci. 2014 Jan;15(1):43-53
pubmed: 24281245
Epilepsia. 2005 Dec;46(12):1898-905
pubmed: 16393155
Epilepsia. 2018 Apr;59(4):745-752
pubmed: 29476535
N Engl J Med. 2018 May 17;378(20):1888-1897
pubmed: 29768152
Neurobiol Dis. 2006 Oct;24(1):128-43
pubmed: 16860990
Brain Dev. 2016 Sep;38(8):772-6
pubmed: 26906012
Neurobiol Dis. 2013 Nov;59:183-93
pubmed: 23938763
J Child Neurol. 2017 Jan;32(1):35-40
pubmed: 27655472
Epilepsia. 2017 Jun;58(6):1102-1111
pubmed: 28448686
J Cereb Blood Flow Metab. 2014 May;34(5):845-51
pubmed: 24569690
J Neuroinflammation. 2015 Jan 28;12:18
pubmed: 25626361
Epilepsy Behav. 2019 Jun;95:117-123
pubmed: 31035103
Epilepsia. 2018 Apr;59(4):739-744
pubmed: 29399791
Semin Pediatr Neurol. 2018 Jul;26:101-103
pubmed: 29961495
Eur J Neurol. 2011 Jul;18(7):952-61
pubmed: 21087361
Eur J Neurosci. 2000 Jul;12(7):2623-33
pubmed: 10947836
Lancet Neurol. 2004 Oct;3(10):608-17
pubmed: 15380157
Neuroscience. 2016 Jul 22;328:22-9
pubmed: 27133574
Front Pharmacol. 2018 Nov 06;9:1157
pubmed: 30459597
Eur J Paediatr Neurol. 2019 Sep;23(5):749-754
pubmed: 31446001
Nat Rev Drug Discov. 2012 Aug;11(8):633-52
pubmed: 22850787
Epilepsia. 2011 Oct;52 Suppl 8:28-30
pubmed: 21967356
Neurobiol Dis. 2011 Dec;44(3):259-69
pubmed: 21645619
Pediatrics. 2014 Nov;134(5):e1431-5
pubmed: 25332495
Seizure. 2013 Sep;22(7):553-9
pubmed: 23643626
Nat Rev Neurol. 2019 Aug;15(8):459-472
pubmed: 31263255
Ann Neurol. 2012 Jul;72(1):82-90
pubmed: 22829270
J Clin Invest. 2017 Jun 1;127(6):2118-2132
pubmed: 28504645
J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1366-72
pubmed: 16170078
Neurobiol Dis. 2003 Dec;14(3):494-503
pubmed: 14678765
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Neurology. 2015 Nov 3;85(18):1604-13
pubmed: 26296517
J Neurosci. 1999 Jun 15;19(12):5054-65
pubmed: 10366638
J Neuroinflammation. 2013 Feb 26;10:30
pubmed: 23442201
Brain Res Bull. 2011 Jul 15;85(6):410-6
pubmed: 21619914

Auteurs

Sookyong Koh (S)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Elaine Wirrell (E)

Child and Adolescent Neurology and Epilepsy, Mayo Clinic, Rochester, MN, USA.

Annamaria Vezzani (A)

Department of Neuroscience, Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Rima Nabbout (R)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker Enfants Malades Hospital, APHP, Imagine Institute, Paris Descartes University, Paris, France.

Eyal Muscal (E)

Department of Pediatrics, Section of Pediatric, Rheumatology, Baylor College of Medicine, Houston, TX, USA.

Marios Kaliakatsos (M)

Department of Neurology, Great Ormond Street Hospital for Children, London, UK.

Ronny Wickström (R)

Neuropediatric Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.

James J Riviello (JJ)

Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Andreas Brunklaus (A)

Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.

Eric Payne (E)

Child and Adolescent Neurology and Epilepsy, Mayo Clinic, Rochester, MN, USA.

Antonio Valentin (A)

Department of Basic and Clinical Neuroscience, Psychology and Neuroscience, Department of Clinical Neurophysiology, King's College Hospital NHS Trust, London, UK.

Elizabeth Wells (E)

Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC, USA.

Jessica L Carpenter (JL)

Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC, USA.

Kihyeong Lee (K)

Comprehensive Epilepsy Center, Advent Health for Children, Orlando, FL, USA.

Yi-Chen Lai (YC)

Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine, Houston, TX, USA.

Krista Eschbach (K)

Department of Pediatrics, Section of Neurology, University of Colorado Denver, Denver, CO, USA.

Craig A Press (CA)

Department of Pediatrics, Section of Neurology, University of Colorado Denver, Denver, CO, USA.

Mark Gorman (M)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Coral M Stredny (CM)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

William Roche (W)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Tara Mangum (T)

Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH